Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening

By Spiekerkoetter Ute  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 5, 2010-10 ,pp. : 527-532

Springer Publishing Company

Access to resources Recommend Favorite

Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects

By Browning M.   Larson C.   Strauss A.   Marsden D.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 4, 2005-06 ,pp. : 545-550

Springer Publishing Company

Access to resources Recommend Favorite

Pathophysiology of fatty acid oxidation disorders

By Bennett M.  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 5, 2010-10 ,pp. : 533-537

Springer Publishing Company

Access to resources Recommend Favorite

Update on mitochondrial fatty acid oxidation disorders

By Spiekerkoetter Ute   Mayatepek Ertan  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 5, 2010-10 ,pp. : 467-468

Springer Publishing Company

Access to resources Recommend Favorite

Potential of fibrates in the treatment of fatty acid oxidation disorders: Revival of classical drugs?

By Djouadi F.   Aubey F.   Schlemmer D.   Gobin S.   Laforet P.   Wanders R.   Strauss A.   Bonnefont J.   Bastin J.  

Journal of Inherited Metabolic Disease, Vol. 29, Iss. 2-3, 2006-04 ,pp. : 341-342

Springer Publishing Company

Access to resources Recommend Favorite